Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Aker BioMarine ASA ( (DE:1PG) ).
Aker BioMarine is set to release its fourth quarter 2024 results on February 12, 2025, with a webcast presentation and a subsequent Q&A session to discuss the outcomes. This announcement provides stakeholders with an opportunity to engage with the company’s management and gain insights into its financial performance and strategic direction.
More about Aker BioMarine ASA
Aker BioMarine is a leading innovator in the human health and nutrition sector, primarily focusing on krill-derived products that promote consumer health. Its portfolio includes Superba Krill Oil, Lysoveta, FloraMarine, PL+, and the consumer brand Kori Krill. The company is also involved in environmental initiatives through spin-offs like AION and Understory. Aker BioMarine is listed on the Oslo Stock Exchange.
YTD Price Performance: -2.69%
Average Trading Volume: 1,000
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €484.1M
See more insights into 1PG stock on TipRanks’ Stock Analysis page.